Study Evaluating the Safety and Tolerability of RCT1100 in Healthy Subjects

Status:
Not yet recruiting

Trial end date:
2025-12-21

Target enrollment:

Participant gender:

This is the first-in-human study with RCT1100 and is designed to provide initial safety and tolerability data for future clinical studies.

Phase 1

ReCode Therapeutics